Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Per the "OLD" Comm Ag

<(c) TPL enters into a reorganization under Chapter 11 of the
United States Bankruptcy Code, and TPL ceases to be a debtor in possession
during the pendency of such bankruptcy proceeding.>

Exactly. TPL has not ceased to be a debtor in possession as far as I know. Do you know something different?

Opty


Share
New Message
Please login to post a reply